CBD Oil and How It Became One of The Fastest Growing Industries Today

Dr. Zora DeGrandpre a naturopathic medicine expert, discusses the latest changes in the CBD market.
Thomas Hughes
LR_FI_money cbd

FX Empire’s Thomas Hughes sat down for an exclusive interview with Leafreport’s DR. Zora DeGrandpre, a certified physician in anti-aging medicine and CME Medical marijuana to discuss the latest developments in the world of CBD and her outlook on the industry.

CBD is a high-growth niche market with a potentially very-lucrative future for investors. Because the buzz around CBD and Publicly traded CBD Companies is heating up, we wanted to cut through the hype to find out what our readers need to know.

What other growth opportunities exist in hemp aside from the CBD market?

CBG is an up-and-coming cannabinoid—it may have broader actions than CBD in some respects—it may have more effects on inflammation and appears to be a more potent anti-tumor agent.

There are well over 100 cannabinoids – any single one of them could potentially be a “growth opportunity”.

There’s also the hemp-fiber aspect—that is likely to be huge as a way to replace plastics and to impact climate change. The hemp plant is also pretty nutritious and resistant to climate change—and there are many areas/growth zones where hemp can be successfully grown.

I just learned that my valley in central Washington was a major hemp-growing area during WW2. I am hearing more and more farmers discussing the viability of growing commercial hemp.

Most of the growth opportunities depend on legislative intelligence—not as big a worry in Washington state, but a big concern across certain parts of the US. Even here in Washington state, until CBD helped reduce his son’s pain, one legislator was vehemently opposed to hemp—proving that logic, science and rational thinking does not move people, but personal experience may.

Legislation has to move with the science—I have little belief in legislator’s understanding of science, but more belief in their willingness to dip into the lobbying purse and suddenly become believers.

Cannabis has to be taken off Schedule I…there is no scientific rationale for its placement there, but I doubt whether that is convincing enough…but until it is taken off Schedule I, the science will be lagging and if the science lags, the potential growth opportunities will lag as well. Also—we don’t know where the FDA will come down on OTC CBD products—that can make or break the industry.

How does the future legalization of recreational cannabis fit into your future plans?

I don’t deal much with recreational cannabis, just the medical actions of CBD/THC. I do think that the psychological addictions of recreational cannabis are not well understood but that it is likely to be similar to alcohol addiction—an under-reported and misunderstood risk for those with addictive tendencies.

There is insufficient research in the pre-psychotic effects of cannabis. People tend to think “Its natural, it feels good, so it couldn’t possibly harm me” and that is out-and-out wrong—cyanide is a natural substance too. Digitalis is medically useful within a very narrow therapeutic window—outside that window, it’s a cardiac toxin.

What risks do you see for the hemp/CBD market in the near term? In the long-term?

CBD is being overblown as a “miracle” cure for everything from ingrown toenails to cancer. That will collapse at some point. It works for certain conditions but will likely be a major disappointment for many others.

There is no wonder drug-human physiological networks are complicated way beyond what we currently understand, and it is unlikely that any single substance will be any magic bullet. People want this but it is not likely.

The science has not yet caught up with the anecdotal evidence—when it does, the hype will calm down somewhat.

The story of vaping should be taken seriously—too many “amateurs” with no integrity got into the market—whatever substance(s) is/are adulterating the vape oils and causing respiratory illnesses will likely be identified and legislators will likely swing the regulatory pendulum way off—and the hemp industry will likely be pulled into a legislative episode of “Reefer Madness”.

What new verticals within the CBD industry do you see opening up in the future?

Depends on the research findings—the apoptotic and anti-inflammatory properties are among the most potentially useful ones.


Dr. Zora DeGrandpre practices naturopathic medicine (home visits) in rural Washington and is a professional medical and scientific writer and editor, specializing in naturopathic, functional, botanical and integrative medicine. Dr. DeGrandpre has degrees in drug design, immunology, and natural medicine and has extensive research experience in cancer and molecular immunology. Dr. DeGrandpre has found the use of CBD with elderly patients and others to be safe and clinically effective

Don't miss a thing!

Discover what's moving the markets. Sign up for a daily update delivered to your inbox

Latest Articles

See All

Expand Your Knowledge

See All
IMPORTANT DISCLAIMERS
The content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your own due diligence checks, apply your own discretion and consult your competent advisors. The content of the website is not personally directed to you, and we does not take into account your financial situation or needs.The information contained in this website is not necessarily provided in real-time nor is it necessarily accurate. Prices provided herein may be provided by market makers and not by exchanges.Any trading or other financial decision you make shall be at your full responsibility, and you must not rely on any information provided through the website. FX Empire does not provide any warranty regarding any of the information contained in the website, and shall bear no responsibility for any trading losses you might incur as a result of using any information contained in the website.The website may include advertisements and other promotional contents, and FX Empire may receive compensation from third parties in connection with the content. FX Empire does not endorse any third party or recommends using any third party's services, and does not assume responsibility for your use of any such third party's website or services.FX Empire and its employees, officers, subsidiaries and associates, are not liable nor shall they be held liable for any loss or damage resulting from your use of the website or reliance on the information provided on this website.
RISK DISCLAIMER
This website includes information about cryptocurrencies, contracts for difference (CFDs) and other financial instruments, and about brokers, exchanges and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and come with a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money.FX Empire encourages you to perform your own research before making any investment decision, and to avoid investing in any financial instrument which you do not fully understand how it works and what are the risks involved.
FOLLOW US